{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibokyesqpynxbmhlk4nh7xfyj45g6r6fh3f7okmrtbbfbyaijtlfa",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3micnia5eyhf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigjm33n3qijx4q36ozbpr3c5fvcuvovr62wka2v7bc63dlfg2hvaq"
    },
    "mimeType": "image/jpeg",
    "size": 53582
  },
  "path": "/pharmalot/2026/03/30/doctors-without-borders-calls-gilead-unconsionable-refuse-sell-hiv-drug/?utm_campaign=rss",
  "publishedAt": "2026-03-30T19:53:10.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "HIV/AIDS",
    "Pharmaceuticals",
    "Policy",
    "public health",
    "STAT+"
  ],
  "textContent": "The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.",
  "title": "STAT+: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization",
  "updatedAt": "2026-03-30T20:24:37.000Z"
}